Eledon Pharmaceuticals (ELDN) Interest & Investment Income (2014 - 2017)
Eledon Pharmaceuticals (ELDN) reported Interest & Investment Income of $26000.0 for Q1 2017, down 51.85% on a YoY basis from $54000.0 in Q1 2016, and up 13.04% quarter-over-quarter from $23000.0 in Q4 2016.
Eledon Pharmaceuticals (ELDN) Interest & Investment Income (2014 - 2017) Analysis & Trends
Eledon Pharmaceuticals has reported Interest & Investment Income for 4 years, with the latest figure at $26000.0 in Q1 2017.
- For the quarter ending Q1 2017, Interest & Investment Income fell 51.85% year-over-year to $26000.0; the trailing twelve-month figure through Mar 2017 stood at $136000.0 (down 27.66% YoY), and the FY2016 full-year result was $164000.0, down 5.75% from the prior year.
- Interest & Investment Income for Q1 2017 stood at $26000.0, up from $23000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $55000.0 in Q4 2015, with the low at $23000.0 in Q4 2016.
- Historically, Interest & Investment Income has averaged $40769.2 across 4 years, with a median of $40000.0 in 2015.
- The largest YoY upside for Interest & Investment Income was 96.0% in 2016 against a maximum downside of 58.18% in 2016.
- Eledon Pharmaceuticals' Interest & Investment Income stood at $53000.0 in 2014, then advanced by 3.77% to $55000.0 in 2015, then plunged by 58.18% to $23000.0 in 2016, then grew by 13.04% to $26000.0 in 2017.
- The last three Interest & Investment Income figures came in at $26000.0 (Q1 2017), $23000.0 (Q4 2016), and $38000.0 (Q3 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Eledon Pharmaceuticals | 401.35 Mn | 185.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 26,000.00 |
| Dec 31, 2016 | 23,000.00 |
| Sep 30, 2016 | 38,000.00 |
| Jun 30, 2016 | 49,000.00 |
| Mar 31, 2016 | 54,000.00 |
| Dec 31, 2015 | 55,000.00 |
| Sep 30, 2015 | 54,000.00 |
| Jun 30, 2015 | 25,000.00 |
| Mar 31, 2015 | 40,000.00 |
| Dec 31, 2014 | 53,000.00 |
| Sep 30, 2014 | 34,000.00 |
| Jun 30, 2014 | 34,000.00 |
| Mar 31, 2014 | 45,000.00 |